HSP-panel testing involving 24 known HSP-related genes including those for SPG11 and ﻿SPG15 in a certified clinical lab, did not confirm the clinical diagnosis of HSP and was negative for HSP-related mutations. This evidence concerns the gene ZFYVE26 and hereditary spastic paraplegia.